Astec Lifesciences Responds to Exchange Query on Volume Increase

Astec Lifesciences Ltd has responded to a stock exchange query regarding a significant increase in trading volume. The company stated that it is conscious of its responsibility to disseminate price-sensitive information promptly and has been compliant with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Astec Lifesciences confirmed that there are no undisclosed developments requiring mandatory disclosure under the Listing Regulations or the Prohibition of Insider Trading Regulations, 2015. They assured continued compliance with all applicable regulations.